Quick Dispatch:
Your igf-1 lr3 cancer risk Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your igf-1 lr3 cancer risk Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance ships.
Need Help?
Questions about igf-1 lr3 cancer risk Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for igf-1 lr3 cancer risk Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance in your area.
Frontiers
24.80
Revisiting the IGF-1R as a breast cancer target
22.32
Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency
26.73
Frontiers
22.03
Recent update on IGF-1/IGF-1R signaling axis as a promising therapeutic target for triple-negative breast cancer
20.36
Frontiers
22.74
Effects of protein restriction on insulin-like growth factor (IGF)-1 in men with prostate cancer: results from a randomized clinical trial | Biomarker Research
24.90
